EGF and breast cancer: Key pathways such as PI3K-Akt signaling, MAPK signaling, and breast cancer are linked with multiple targets including BRCA1, FGFR1, IGF1, AKT1, and EGF, suggesting their potential involvement in breast cancer pathology influenced by PCBs exposure.